Locoregional Stomach Cancer

Gastric Adenocarcinoma

Male, 67 years

Patient Internal ID: 651733067

ICD-10 code

C16.8 Malignant Neoplasm of Overlapping Sites of Stomach

Diagnosis (Incl. Metastases/Stage) and Year

May 2020
Gastric Adenocarcinoma cT3N1M1 G3 Stage IV, Metastases in the Liver.

Previous Treatment

Chemotherapy (Cisplatin and Oxaliplatin).

Prognosis and Survival Expectation

The prognosis remains poor, with a median survival of 6 to 14 months from diagnosis or 5-year relative survival of 3%.

Treatment Provided

Autologous DCV (5 doses) and CIK (4 doses) over a period of 7 months. Additionally, the patient received Umbilical Cord Blood Derived NK Cells (5 doses).

Patient Survival/Condition and Year
Date of Review: 02/01/2024

The patient has survived for 38 months since the diagnosis. It can be concluded that the addition of Immunotherapy, alongside Chemotherapy, has extended patient survival by an estimate of 24 to 32 months.